Research News

Sanders-Brown study: Long-read RNA sequencing reveals key gene expressions in Alzheimer’s disease

Jun 6, 2024, 7:21 AM

Researchers at UK's Sanders-Brown Center on Aging are working to develop a pre-symptomatic disease diagnostic tool for Alzheimer’s disease.

Yolanda%20Jackson%20focus%20group%20photo%202024.jpg

Addressing disparities in Alzheimer's disease through culturally tailored health information

May 22, 2024, 7:04 AM

Frankfort, Kentucky, has the nation’s second-highest prevalence of Alzheimer’s in Black adults. Yolanda Jackson, a clinician dietitian pursuing a Ph.D. in health communications, is working to develop accessible information about modifiable risk factors for the disease.

UK researchers explore the relationship between Down syndrome and Alzheimer's disease

Mar 20, 2024, 7:24 AM

Thanks to medical advances, people with Down syndrome are living longer and fuller lives; however there is still much to learn about the Down syndrome brain.

Chemicals in plastics could be a risk factor for Alzheimer’s

Feb 28, 2024, 7:18 AM

Researchers at the University of Kentucky are studying how elements of our natural surroundings can be potential risk factors for Alzheimer’s disease — including chemicals widely used in plastics.

UK researchers 1st to show multiple sclerosis drug can be used as Alzheimer’s therapy

Sep 1, 2023, 6:58 AM

A team of researchers at the University of Kentucky has found that a drug used to treat multiple sclerosis (MS) is potentially effective as a therapy for Alzheimer’s disease.

Sanders-Brown Center on Aging featured in special on WKYT this Monday

Aug 31, 2023, 6:48 AM

Labor Day, September 4, WKYT-TV, is highlighting the world-class work going on at the University of Kentucky’s Sanders-Brown Center on Aging. The Lexington-based CBS affiliate will air a 30-minute special on their second station, The CW, at 6:30 p.m.

New study shows anti-inflammatory drugs as a promising target for Alzheimer’s disease

Jul 17, 2023, 7:03 AM

A recent study from the lab of the Sanders-Brown Center on Aging Director Linda Van Eldik, Ph.D., centers around the idea that various anti-inflammatory drugs could be effective treatments for Alzheimer’s disease.

Drug studied at UK is 1st disease-modifying therapy in U.S. approved to treat Alzheimer’s

Jul 12, 2023, 7:07 AM

The U.S. Food and Drug Administration (FDA) granted full approval to lecanemab, marketed as Leqembi, for the treatment of Alzheimer’s disease. The University of Kentucky’s Sanders-Brown Center on Aging has been working with this drug and others like it for more than a decade.

Allison%20Gibson%20Frame%20Grab%20-%202.jpg

Women Making History: UK researcher helps caregivers navigate Alzheimer's challenges

Mar 1, 2023, 7:09 AM

Throughout March, UK is spotlighting Women Making History. These women are leading their fields of research and impacting the lives of Kentuckians. For Allison Gibson, Ph.D., her passion is helping some of the most vulnerable Kentuckians.

Promising Alzheimer's drug being studied at UK's Sanders-Brown Center on Aging receives FDA approval

Jan 30, 2023, 7:05 AM

The University of Kentucky is a site for the groundbreaking AHEAD study, the first-ever clinical trial to test the effect of a promising drug known as lecanemab.

Filter News

Unit

News type

Topic

Series